A prognostic model using 14 autophagy-related lncRNAs (such as ABALON, NKILA, AC092171.2, and others) was capable of accurately predicting the 3-year survival rate of NSCLC patients (AUC = 0.625; sensitivity 78.2%; specificity 72.5%) [126]. Here, ABALON is linked to non-small cell lung carcinoma.